Laura Sepp-Lorenzino - EVP, Chief Scientific Officer at Intellia Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
EVP, Chief Scientific Officer
Issuer Symbol
NTLA on Nasdaq
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Laura Sepp-Lorenzino since 24 Feb 2025

Holdings reported by Laura Sepp-Lorenzino for Intellia Therapeutics, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 77,388 $942,586 $12.18 03 Jan 2025 Direct
Stock Option (right to buy) 54,794 01 Mar 2024 Direct Common Stock
Restricted Stock Unit 0 01 Jan 2025 Direct Common Stock

Transactions reported by Laura Sepp-Lorenzino for Intellia Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.